262 related articles for article (PubMed ID: 10030274)
1. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
[TBL] [Abstract][Full Text] [Related]
2. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
3. The impact of edema on planning 125I and 103Pd prostate implants.
Yue N; Dicker AP; Nath R; Waterman FM
Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostatic edema on CT-based postimplant dosimetry.
Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
[TBL] [Abstract][Full Text] [Related]
5. Effect of post-implant edema on the rectal dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):571-6. PubMed ID: 10524408
[TBL] [Abstract][Full Text] [Related]
6. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
7. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Yue N; Chen Z; Nath R
Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
[TBL] [Abstract][Full Text] [Related]
8. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
[TBL] [Abstract][Full Text] [Related]
9. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Waterman FM; Yue N; Corn BW; Dicker AP
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
[TBL] [Abstract][Full Text] [Related]
10. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
Butler WM; Merrick GS; Dorsey AT; Lief JH
Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
[TBL] [Abstract][Full Text] [Related]
11. Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
Van Gellekom MP; Moerland MA; Kal HB; Battermann JJ
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):422-33. PubMed ID: 12023147
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
13. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):610-21. PubMed ID: 12062604
[TBL] [Abstract][Full Text] [Related]
14. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
15. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Walbert HL
Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
[TBL] [Abstract][Full Text] [Related]
16. Isotope selection for patients undergoing prostate brachytherapy.
Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
18. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema.
Monajemi TT; Clements CM; Sloboda RS
Med Phys; 2011 Apr; 38(4):2289-98. PubMed ID: 21626964
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Chen Z; Yue N; Wang X; Roberts KB; Peschel R; Nath R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1405-19. PubMed ID: 10889396
[TBL] [Abstract][Full Text] [Related]
20. Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.
Kehwar TS; Jones HA; Huq MS; Smith RP
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):621-7. PubMed ID: 20932692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
